Amgen Долг / собственный капитал

Что обозначает Долг / собственный капитал в Amgen?

Долг / собственный капитал Amgen, Inc. является 2.24

Какое определение для Долг / собственный капитал?

Соотношение долга к собственному капиталу - это финансовое соотношение, показывающее относительную пропорцию собственного капитала и долга, используемых для финансирования активов компании.

The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.

Долг / собственный капитал компаний в Health Care сектор на XETRA по сравнению с Amgen

Что делает Amgen?

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with BehÃ§et's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and a strategic research and development collaboration with Neumora Therapeutics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Компании с долг / собственный капитал похож на Amgen

Bunge имеет Долг / собственный капитал из 2.24
Eveready Industries India имеет Долг / собственный капитал из 2.24
Ashnoor Textile Mills имеет Долг / собственный капитал из 2.24
Rashtriya Chemicals and Fertilizers имеет Долг / собственный капитал из 2.24
Keller Plc имеет Долг / собственный капитал из 2.24
China Molybdenum Co имеет Долг / собственный капитал из 2.24
Amgen имеет Долг / собственный капитал из 2.24
Glencore Plc имеет Долг / собственный капитал из 2.24
Glencore Plc имеет Долг / собственный капитал из 2.24
Inox Wind имеет Долг / собственный капитал из 2.24
Viasat имеет Долг / собственный капитал из 2.24
Dividend 15 Split имеет Долг / собственный капитал из 2.24
PRGX Global Inc имеет Долг / собственный капитал из 2.24